Navigation Links
FDA Approves New Medicine BRILINTA™ (Ticagrelor) for Use in the US
Date:7/20/2011

WILMINGTON, Del., July 20, 2011 /PRNewswire/ -- AstraZeneca (NYSE: AZN) announced today that the US Food and Drug Administration (FDA) has approved BRILINTA™ (ticagrelor) tablets to reduce the rate of heart attack (myocardial infarction [MI]) and cardiovascular (CV) death in adult patients with acute coronary syndrome (ACS), compared to clopidogrel.

To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/astrazeneca/50355/

BRILINTA, a new oral antiplatelet medicine, is indicated to reduce the rate of thrombotic cardiovascular events in patients with ACS (unstable angina [UA] non-ST-elevation myocardial infarction [NSTEMI], or ST-elevation myocardial infarction [STEMI]). BRILINTA has been shown to reduce the rate of a combined endpoint of CV death, MI or stroke compared to clopidogrel. The difference between treatments was driven by CV death and MI with no difference in stroke. In patients treated with an artery-opening procedure known as percutaneous coronary intervention (PCI), BRILINTA reduces the rate of stent thrombosis. BRILINTA has been studied in ACS in combination with aspirin. Maintenance doses of aspirin above 100 mg decreased the effectiveness of BRILINTA. Avoid maintenance doses of aspirin above 100 mg daily.

David Brennan, Chief Executive Officer, AstraZeneca said: "The FDA approval of BRILINTA is good news for patients in the United States and represents a significant milestone as we seek to help ensure ACS patients around the world have access to this innovative medicine. With over one million people affected by ACS in the US each year, the fact that physicians have a new and more effective treatment option than clopidogrel to help reduce the rate of heart attack and cardiovascular death in these patients is an important adv
'/>"/>

SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves Vaccines for the 2011-2012 Influenza Season
2. FDA Approves Boostrix to Prevent Tetanus, Diphtheria, and Pertussis in Older People
3. FDA Approves Arcapta Neohaler to Treat Chronic Obstructive Pulmonary Disease
4. FDA Approves XARELTO® (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery
5. FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
6. FDA Approves First Generic Versions of the Antibiotic Levofloxacin to Treat Certain Infections
7. FDA Approves Nulojix for Kidney Transplant Patients
8. FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment
9. FDA Approves First Ceramic-on-Metal Total Hip Replacement System
10. FDA Approves Redesigned Labels for Some Merck Drugs
11. FDA Approves Updates to Lillys Humalog® (insulin lispro injection [rDNA origin]) Label
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015 TeraRecon, ( www.terarecon.com ), ... Unternehmen, baut seine Präsenz im EMEA-Markt mit ... of Sales und Stefan Phillips ... Logo - http://photos.prnewswire.com/prnh/20150303/179359LOGO ... den Verkauf und die Geschäftsentwicklung in Europa ...
(Date:3/4/2015)... MIAMI , March 4, 2015 ... or the "Company"), a medical technology company that ... ideas announced today that the Company,s subsidiary, Thermomedics, ... Director of Specialty and Government Sales. LeBel will ... of Marketing and Sales, and will be responsible ...
(Date:3/4/2015)... , Israël, 4 mars ... (NASDAQ/TASE : RDHL) (« RedHill » ou la ... centrée principalement sur les spécialités ... à un stade clinique avancé ... gastro-intestinales, dont notamment les cancers ...
Breaking Medicine Technology:TeraRecon baut seine Präsenz in EMEA aus 2TeraRecon baut seine Präsenz in EMEA aus 3Sanomedics Hires Scott W. LeBel as Director of Specialty and Government Sales 2Sanomedics Hires Scott W. LeBel as Director of Specialty and Government Sales 3RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 2RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 3RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 4RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 5
... NEW YORK, Dec. 14, 2011 ... research report is available in its ... Monitoring Market Outlook to 2017 - ... Monitors, Non-Invasive Blood Pressure Monitors, Remote ...
... 2011 Reportlinker.com announces that a ... in its catalogue: ... Market Outlook to 2017 - Ultrasound ... Nuclear Imaging Equipment, X-Ray Systems, Mammography ...
Cached Medicine Technology:Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others 2Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others 3Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others 4Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others 5Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others 6Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others 7Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others 8Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others 9Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others 10Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others 11Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others 12Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others 13Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others 14Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 2Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 3Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 4Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 5Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 6Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 7Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 8Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 9Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 10Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 11Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 12Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 13Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 14Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others 15
(Date:3/4/2015)... March 04, 2015 More than a ... risks potentially associated with low testosterone treatments ( http://www.testosteronelawsuithub.com/ ... that it will now require manufacturers to warn patients ... for heart attacks and strokes. In a Drug ... also stated that it was requiring testosterone manufacturers to ...
(Date:3/4/2015)... Vancouver, BC (PRWEB) March 04, 2015 ... Center, has recently received two awards in the ... Choice Awards on February 27, 2015. The company ... and second place in the “Best Registered Massage ... largest distributed community newspapers in Canada, The Vancouver ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The print ... of The San Francisco Chronicle with a circulation of ... readers. Its digital component is distributed nationally through a ... top news sites and partner outlets. To explore the ... , Milorganite is composed of heat-dried microbes that ...
(Date:3/4/2015)... Atlanta, Georgia (PRWEB) March 04, 2015 ... Georgia, part of the School of Public Health at ... , The funds were awarded by Georgia’s Division of ... contract to support the DFCS Call Center. , ... child maltreatment by providing information and referral services that ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The ... $236.8 billion in 2014 and is estimated to ... CAGR of 4.0% from 2014 to 2019. , ... Gas Market for an analysis of industry trends, ... The global liquefied petroleum gas market is classified ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 2Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 3
... federal scanner, which has pointed out a 4% decline in ... Department of Health and Human Service has attributed this drop ... 1996 to 2003- to the spiraling growth in expenditures on ... ,The Agency for Healthcare Research and Quality in Health ...
... protein called nestin to a particularly deadly form of ... to earlier detection and better treatment.// ,In ... Dartmouth Medical School demonstrate that nestin could represent a ... highly aggressive cancer with similarities to mammary stem cells, ...
... chronic obstructive pulmonary disease (COPD), combining a long-acting ... of exacerbations by 35 percent.// ,Peter Kardos, ... Hospital in Frankfurt am Main, Germany, and three ... from 92 respiratory centers across Germany. All had ...
... from a special study by UK’S Metropolitan police, stating that ... crime and //anti- social behavior has put the spotlight on ... (BMA), in their report: Gambling Addiction and its Treatment within ... out with stronger support and treatment for gamblers, as gambling ...
... too much of unhealthy trans fats present in many fried ... ,Scientists at the Harvard School of Public Health found that ... fats than fertile women, reported the online edition of health ... that is formed when vegetable oils are hardened into margarine ...
... lipid-based nanoparticles drastically reduces the number and size ... mice, researchers at The University of Texas M. ... Texas Southwestern Medical Center report in the Jan. ... genes given intravenously reduced cancer separately but had ...
Cached Medicine News:Health News:Selective Marker Found to Indicate Aggressive Form of Breast Cancer 2Health News:Selective Marker Found to Indicate Aggressive Form of Breast Cancer 3Health News:Gambling to Be Taken as a Serious Addiction, Warns BMA 2Health News:Dual Gene Therapy Suppresses Lung Cancer in Preclinical Test 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: